Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
<strong>Background:</strong> Studies show that mepolizumab can reduce the frequency of clinically significant exacerbations in patients with severe eosinophilic asthma, compared with placebo. However, important events such as hospitalizations and emergency room visits are rare and diffi...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2016
|